ACE2 and cardiovascular disorder: While ACE2 acts as a receptor for SARS CoVs, human ACE2 SNVs have been reported to be associated with cardiovascular diseases, hypertension, and diabetic mellitus, all of which are recognized as risk factors for severe clinical outcomes in COVID-19 patients (20, –, 22).